Enzo Biochem Inc (ENZ.N)
ENZ.N on New York Stock Exchange
3.81USD
25 Sep 2018
3.81USD
25 Sep 2018
Change (% chg)
$-0.03 (-0.78%)
$-0.03 (-0.78%)
Prev Close
$3.84
$3.84
Open
$3.86
$3.86
Day's High
$3.96
$3.96
Day's Low
$3.81
$3.81
Volume
36,510
36,510
Avg. Vol
35,193
35,193
52-wk High
$11.49
$11.49
52-wk Low
$3.81
$3.81
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Apr '18 | 25.63 | -0.064 |
| Jan '18 | 26.95 | -0.043 | |
| Oct | 27.68 | -0.014 | |
| FY 2017 | Jul '17 | 28.17 | 0.002 |
| Apr '17 | 27.09 | -0.002 | |
| Jan '17 | 26.26 | -0.023 | |
| Oct | 26.28 | -0.032 | |
| FY 2016 | Jul '16 | 26.60 | 0.768 |
| Apr '16 | 26.43 | -0.046 | |
| Jan '16 | 24.56 | 0.147 | |
| Oct | 25.18 | 0.096 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Apr-18 | 1 | 27.92 | 27.92 | 27.92 | -- |
| Quarter Ending Jul-18 | 1 | 25.26 | 25.26 | 25.26 | 29.10 |
| Year Ending Jul-18 | 1 | 105.52 | 105.52 | 105.52 | 112.70 |
| Year Ending Jul-19 | 1 | 112.94 | 112.94 | 112.94 | -- |
| Earnings (per share) | |||||
| Quarter Ending Apr-18 | 1 | -0.02 | -0.02 | -0.02 | -- |
| Quarter Ending Jul-18 | 1 | -0.06 | -0.06 | -0.06 | 0.01 |
| Year Ending Jul-18 | 1 | -0.18 | -0.18 | -0.18 | -0.03 |
| Year Ending Jul-19 | 1 | -0.04 | -0.04 | -0.04 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 35.77 | 32.55 | |
| P/E High - Last 5 Yrs. | 7.17 | 111.04 | 47.13 | |
| P/E Low - Last 5 Yrs. | 7.17 | 26.09 | 24.86 | |
| Beta | 1.07 | 0.49 | 0.87 | |
| Price to Sales (TTM) | 1.66 | 6.49 | 6.32 | |
| Price to Book (MRQ) | 2.08 | 3.59 | 3.96 | |
| Price to Tangible Book (MRQ) | 2.34 | 5.55 | 6.00 | |
| Price to Cash Flow (TTM) | -- | 18.39 | 22.84 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.00 | 1.68 | |
| Dividend Yield - 5 Year Avg | -- | 0.83 | 1.45 | |
| Dividend 5 Year Growth Rate | -- | 7.08 | -5.90 | |
| Payout Ratio(TTM) | -- | 31.40 | 46.65 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -5.39 | 7.20 | 8.33 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 2.06 | 9.15 | 6.69 | |
| Sales - 5 Yr. Growth Rate | 0.90 | 12.53 | 7.54 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -4,087.58 | -71.22 | 25.23 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -116.62 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 5.74 | 7.60 | |
| Capital Spending - 5 Yr. Growth Rate | 5.15 | 12.81 | 8.36 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 4.24 | 3.75 | 2.21 |
| Current Ratio (MRQ) | 4.63 | 3.92 | 2.98 |
| LT Debt to Equity (MRQ) | 0.47 | 38.57 | 11.20 |
| Total Debt to Equity (MRQ) | 0.71 | 44.24 | 14.01 |
| Interest Coverage (TTM) | -4.34 | 29.56 | 34.72 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 43.39 | 38.78 | 54.70 | |
| Gross Margin - 5 Yr. Avg. | 43.65 | 42.49 | 53.20 | |
| EBITD Margin (TTM) | 0.40 | -- | -- | |
| EBITD - 5 Yr. Avg | -1.77 | 12.15 | 15.84 | |
| Operating Margin (TTM) | -6.48 | 9.04 | 3.87 | |
| Operating Margin - 5 Yr. Avg. | 2.73 | 5.89 | 10.99 | |
| Pre-Tax Margin (TTM) | -5.15 | 8.34 | 4.20 | |
| Pre-Tax Margin - 5 Yr. Avg. | 2.60 | 6.97 | 11.19 | |
| Net Profit Margin (TTM) | -5.13 | 5.67 | 0.91 | |
| Net Profit Margin - 5 Yr. Avg. | 2.47 | 4.25 | 7.51 | |
| Effective Tax Rate (TTM) | -- | 19.39 | 20.56 | |
| Effective Tax Rate - 5 Yr. Avg. | 5.13 | 28.00 | 24.33 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 250,413 | 8,486,480 | 725,212,627 | |
| Net Income/Employee (TTM) | -12,848 | -215,625 | 83,818,761 | |
| Receivable Turnover (TTM) | 7.18 | 7.34 | 5.04 | |
| Inventory Turnover (TTM) | 8.50 | 63.22 | 3.63 | |
| Asset Turnover (TTM) | 1.02 | 0.55 | 0.82 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -5.25 | 5.25 | 9.83 | |
| Return on Assets - 5 Yr. Avg. | 3.13 | 6.83 | 10.96 | |
| Return on Investment (TTM) | -6.31 | 6.68 | 12.80 | |
| Return on Investment - 5 Yr. Avg. | 4.38 | 8.56 | 14.08 | |
| Return on Equity (TTM) | -6.36 | 9.86 | 14.92 | |
| Return on Equity - 5 Yr. Avg. | 4.51 | 12.36 | 15.41 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 4.90 | 3.96 | 0.90 |
| EPS (TTM) % | -105.56 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Enzo Biochem Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -15.42 | -16.07 | 44 | 14 |
| 13 Week | -27.68 | -32.69 | 46 | 37 |
| 26 Week | -32.75 | -38.76 | 54 | 50 |
| 52 Week | -63.25 | -68.50 | 27 | 61 |
| YTD | -52.88 | -56.85 | 30 | 62 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 71.59% |
| # of Holders: | 131 |
| Total Shares Held: | 33,764,903 |
| 3 Mo. Net Change: | 610,602 |
| # New Positions: | 12 |
| # Closed Positions: | 28 |
| # Increased Positions: | 51 |
| # Reduced Positions: | 70 |
| # Net Buyers: | -19 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.